Norges Bank’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-974,050
Closed -$14.5M 1945
2023
Q4
$14.5M Sell
974,050
-133,565
-12% -$1.99M ﹤0.01% 1360
2023
Q3
$17.9M Buy
1,107,615
+5,015
+0.5% +$81K ﹤0.01% 1271
2023
Q2
$45.8M Buy
1,102,600
+25,682
+2% +$1.07M 0.01% 902
2023
Q1
$64.8M Buy
1,076,918
+103,265
+11% +$6.21M 0.01% 719
2022
Q4
$71.4M Buy
973,653
+20,090
+2% +$1.47M 0.02% 654
2022
Q3
$72.5M Buy
953,563
+34,133
+4% +$2.59M 0.02% 625
2022
Q2
$63.9M Buy
919,430
+26,469
+3% +$1.84M 0.02% 663
2022
Q1
$74M Buy
892,961
+24,723
+3% +$2.05M 0.02% 697
2021
Q4
$65.2M Buy
868,238
+45,949
+6% +$3.45M 0.01% 804
2021
Q3
$95.5M Buy
822,289
+12,186
+2% +$1.42M 0.02% 634
2021
Q2
$180M Sell
810,103
-2,031
-0.3% -$451K 0.04% 444
2021
Q1
$107M Sell
812,134
-44,712
-5% -$5.91M 0.02% 612
2020
Q4
$148M Buy
856,846
+29,899
+4% +$5.17M 0.03% 456
2020
Q3
$92M Buy
826,947
+81,254
+11% +$9.04M 0.02% 569
2020
Q2
$44.2M Sell
745,693
-32,000
-4% -$1.9M 0.01% 914
2020
Q1
$52.4M Hold
777,693
0.02% 676
2019
Q4
$65.5M Hold
777,693
0.02% 742
2019
Q3
$58.2M Sell
777,693
-18,527
-2% -$1.39M 0.02% 784
2019
Q2
$50.3M Sell
796,220
-82,615
-9% -$5.22M 0.02% 878
2019
Q1
$42.3M Buy
878,835
+28,425
+3% +$1.37M 0.01% 964
2018
Q4
$28.5M Buy
850,410
+29,726
+4% +$995K 0.01% 1156
2018
Q3
$43M Buy
820,684
+61,686
+8% +$3.23M 0.01% 979
2018
Q2
$23.8M Hold
758,998
0.01% 1397
2018
Q1
$16.5M Buy
758,998
+199,656
+36% +$4.35M 0.01% 1548
2017
Q4
$11.3M Buy
559,342
+110,122
+25% +$2.22M ﹤0.01% 1701
2017
Q3
$8.92M Buy
+449,220
New +$8.92M ﹤0.01% 1769
2016
Q2
Sell
-112,900
Closed -$1.64M 2187
2016
Q1
$1.64M Buy
112,900
+37,900
+51% +$549K ﹤0.01% 2010
2015
Q4
$1.68M Buy
+75,000
New +$1.68M ﹤0.01% 2054